HOME   |    PDF   |   


Title

Outcomes of pancreaticoduodenectomy in chronic liver disease

 

Authors

Shashi Shashi*, Subhashish Das, Suvendu S. Jena, Sri Aurobindo Prasad Das, Amitabh Yadav & Samiran Nundy

 

Affiliation

Institute of Surgical Gastroenterology, GI & HPB Oncosurgery and Liver Transplant, Sir Ganga Ram Hospital, New Delhi, India; *Corresponding author

 

Email

Shashi Shashi - E-mail: shashikush334@gmail.com
Subhashish Das - E-mail: subhamsubham1@yahoo.co.in
Suvendu S. Jena - E-mail: suvu1078@gmail.com
Sri Aurobindo Prasad Das - E-mail: aurobindodas84@gmail.com
Amitabh Yadav - E-mail: amitabhyadav99@gmail.com
Samiran Nundy - E-mail: snundy@hotmail.com

 

Article Type

Research Article

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Pancreaticoduodenectomy (PD) in chronic liver disease (CLD) carries increased perioperative risk. We retrospectively analysed 28 Child-Pugh A/B patients undergoing PD between 2008 and 2024. Median operative time was 420 minutes, blood loss 600 mL and 30day mortality 10.7%. Hepatic decompensation occurred in 44.8%; median survival was 309.5 days, with 2-year survival of 50%. Thus, PD is feasible in carefully selected patients, but hepatic and infective complications remain substantial.

 

Keywords

Pancreaticoduodenectomy (PD), chronic liver disease (CLD), Whipple's surgery

 

Citation

Shashi et al. Bioinformation 22(10): 7050-7055 (2026)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.